The table below shows Roivant Sciences Ltd.'s cash flow statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q2 2025
Q2 2024
Q2 2023
Q2 2022
Q2 2021
Q2 2020
Operating cash flow
-$204.38M
-$192.83M
-$249.93M
-$252.08M
-$141.17M
-$111.17M
Capital expenditure
$4.04M
$965.00K
$403.00K
$7.46M
$2.34M
$306.00K
Investing cash flow
-$1.09B
-$965.00K
$105.00K
-$7.46M
-$2.34M
-$25.64M
Dividends paid
-
-
-
ROIV operating cash flow (10-K history)
Roivant Sciences Ltd. reported operating cash flow of -$750.35M for fiscal year 2026. That is up 10.6% from -$839.45M in fiscal 2025. Over the 6 fiscal years shown, operating cash flow declined from -$552.14M (FY 2021) to -$750.35M. Figures come from the company's audited annual reports as filed with the SEC.
